Adding Immunomedics (IMMU) $3.00 to Watch List.
Biotech Stock Review Initiates Coverage.
Immunomedics (IMMU). $3.00 Epic Short Squeeze Inflection Point Nears.
As posted on SeekingAlpha.
Largest Stem Cell Investor Conference Set to Be Held in New York City
Where Stem Cell Science, Meets Wall Street
NEW YORK, NY--(Marketwired - Oct 6, 2015) - Investor Conference Network will be holding what many are calling...
CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground Running.
“Announces Partnership With Caron Foundation, Ranked Amongst Top 7 Treatment Centers in US with Revenues Approaching $100 million.”
On August 20th CNS-Wellness, a wholly owned...
Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.
Erin Drought, a 28-year-old information technology consultant in Edmonton, Alberta, who says her sex drive evaporated after she began taking medicine for bipolar disorder,...
Christopher E. Rivera Appointed to the Council of Washington Biotechnology & Biomedical Association
WASHINGTON, DC and SEATTLE, WA – (June 27, 2011) – Today the Washington Biotechnology & Biomedical Association (WBBA) and the Biotechnology Industry Organization (BIO)...
Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.
Download Circle Group - Z-Trim Report
Circle Group Holdings (CRGQ) $0.47 Report.
Click to Download.
Client, we were compensated with 100,000 shares and warrants to purchase 200,000 shares in the open market.
Latest article
Adding BCM Resources Corporation (B.V) $0.27, Up 42%, to Watch List.
'Elephant Hunter' Dr. Sergei Diakov is Expanding Drill Footprint, to Outline a Potentially Massive Copper-Gold System Beneath the Surface.
Led by legendary geologist Dr. Sergei...
New Report on Sekur Private Data (SWISF). Palantir’s Open Secure AI.
Palantir CEO Alex Karp discusses open-weight artificial intelligence models, how he believes the technology should be regulated and why the U.S. should avoid Europe’s...
Replimune (REPL) Jumps 100%.
A Nifty $415 Million Gain (in an hour) for Shareholders.
Not out of the woods yet..
Short and to the point: We listened to whole meeting...
